Work

A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population

Year: 2013

Type: article

Source: Immunogenetics

DOI: 10.1007/s00251-013-0684-y

Authors: Denise M. McKinney, Scott Southwood, Denise Hinz, Carla Oseroff, Cecilia S. Lindestam Arlehamn, Veronique Schulten, Randy Taplitz, David Broide, Willem A. Hanekom, Thomas J. Scriba, Robert Wood, Rafeul Alam, Bjoern Peters, John Sidney, Alessandro Sette

Institutions: La Jolla Institute for Immunology, University of California San Diego, University of Cape Town, South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Johns Hopkins University, National Jewish Health

Language: English

Topic: vaccines and immunoinformatics approaches

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bill and Melinda Gates Foundation, Wellcome Trust, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: G1193040595, G1661652398, G2384563179, G2902033169, G3960898640, LIAI Epitope Validation Center: Characterization of Allergen specific T Cells, G5880186146, University of Cape Town - to identify predictive gene expression signatures of risk of tuberculosis (TB) disease, following natural infection with Mycobacterium tuberculosis..., G6771748658, G6802035232, G7288706264, G76681233, G9000200135

OpenAlex ID: W2091376804

FWCI: 3.765

Cites: 68

Cited by: 78

Related to: 10